Qualigen Therapeutics Inc is a biotechnology company focused on the development and commercialization of novel therapeutic products for the treatment of cancer and infectious diseases using nanoparticle coating technology. Qualigen Therapeutics Inc is a biotechnology company focused on the development and commercialization of novel therapeutic products for the treatment of cancer and infectious diseases using nanoparticle coating technology.
CARLSBAD, Calif., Sept. 20, 2024 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (the “Company”) today announced that on September 11, 2024, the Company received a notice from...
New York, Sept. 06, 2024 (GLOBE NEWSWIRE) -- Univest Securities, LLC (“Univest”), a member of FINRA and SIPC, and a full-service investment bank and securities broker-dealer firm based in New...
CARLSBAD, Calif., Sept. 06, 2024 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (the “Company”) today announced the closing of its previously announced public offering of...
CARLSBAD, Calif., Sept. 05, 2024 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (the “Company”) today announced the pricing of a public offering of 14,724,058 shares of common...
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.0019 | -1.0863350486 | 0.1749 | 0.1776 | 0.1605 | 257033 | 0.16924697 | CS |
4 | -0.015 | -7.97872340426 | 0.188 | 0.198086 | 0.141 | 316744 | 0.16584245 | CS |
12 | -0.1983 | -53.4069485591 | 0.3713 | 0.5887 | 0.141 | 12514920 | 0.36988243 | CS |
26 | -0.2102 | -54.8538622129 | 0.3832 | 0.5887 | 0.141 | 6392033 | 0.35219572 | CS |
52 | -0.807 | -82.3469387755 | 0.98 | 1.1 | 0.141 | 3239045 | 0.35319375 | CS |
156 | -13.827 | -98.7642857143 | 14 | 31.2 | 0.141 | 1999895 | 7.55031007 | CS |
260 | -72.327 | -99.7613793103 | 72.5 | 79 | 0.141 | 1751090 | 14.44506819 | CS |
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約